Cysticercosis overview

Revision as of 14:37, 20 April 2017 by Usama Talib (talk | contribs)
Jump to navigation Jump to search

Cysticercosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cysticercosis from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Case Studies

Case #1

Cysticercosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cysticercosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cysticercosis overview

CDC on Cysticercosis overview

Cysticercosis overview in the news

Blogs on Cysticercosis overview

Directions to Hospitals Treating Cysticercosis

Risk calculators and risk factors for Cysticercosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Adult Taenia Solium

Adult Taenia Solium - © Copyright UAB and the UAB Research Foundation, 1999-2013. All rights reserved

Historical Perspective

  • The earliest reference to tapeworms was found in the works of ancient Egyptians that date back to almost 2000 BC.[1].Cysticercosis is caused by the infestation of the larvae of Taenia Solium to various tissues (Brain, Muscles, eye .. etc).

Pathophysiology

  • Humans develop cysticercosis by ingesting Taenia solium eggs. Following ingestion, oncospheres hatch, have access to the circulation and infect various tissues. During the viable phase, cysts do not cause marked inflammation nor symptoms. As the cysts degenerate, they lose the ability to modulate the immune response and result in an immune attack and tissue injury and edema. Eventually, the cysts either resolve or form a calcified granuloma, which is associated with seizures if it is located in the brain.

Classification

  • Cysticercosis is classified according to the site of cysticerci into Neurocysticercosis and extraneural cysticercosis. Neurocysticercosis is further subdivided into Parenchymal and extra-parenchymal.

Epidemiology and Demographics

  • Cysticercosis is more prevalent in underdeveloped countries in Africa, Latin America and Southeast Asia, especially in rural areas where humans are in direct contact with pigs and sanitary conditions, are not optimum.

Risk Factors

  • Poor sanitary habits, contact with pigs and living in an endemic area are the main risk factors for having cysticercosis.

Screening

  • Patients with cysticercosis and their household should be screened for intestinal tapeworm. High-risk persons should be screened for cysticercosis if they are to be employed as food handlers or housekeepers.

Natural History, Complications and Prognosis

  • Cysticercosis is treated easily with antihelminthic drugs and even untreated patients can remain silent for long periods. Complications can develop in the intestine if the tapeworm grows enough to cause obstructions or at the sites of cysticerci when they start to degenerate and provoke the immune system.

Symptoms and Physical Examination

Diagnostic tests

  • There is no single gold standard for diagnosing cysticercosis (except for biopsy which is rarely done). Diagnosis is made by combing data from various investigation and suspecting the disease. A set of diagnostic criteria was proposed in 2001 based on a combination of epidemiological factors, clinical manifestations, laboratory and radiological investigations.
  • Computerized tomography (CT) is superior to magnetic resonance imaging (MRI) for demonstrating small calcifications. However, MRI shows cysts in some locations (cerebral convexity, ventricular ependyma) better than CT, is more sensitive than CT to demonstrate surrounding edema and may show internal changes indicating the death of cysticerci.

Treatment

  • Cysticercosis is generally treated with a combination of both anti-parasitic drugs and anti-inflammatory drugs. Symptomatic treatment is the mainstay therapy for neurocysticercosis. Surgical removal is sometimes necessary to treat ophthalmic cysticercosis and subcutaneous cysticercosis.
  • Surgery is not the first line of treatment except in ocular cysticercosis and other certain cases of neurocysticercosis.

Primary Prevention

  • Prevention against intestinal taeniasis is the main strategy for prevention of cysticercosis.


References

  1. Wadia, NH, Singh, G. “Taenia Solium: A Historical Note” Taenia Solium Cysticercosis: From Basic to Clinical Science CABI Publishing, 2002. 157-168.